Working… Menu

AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (INHIBITOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02780830
Recruitment Status : Withdrawn (Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an alternate design.)
First Posted : May 24, 2016
Last Update Posted : September 15, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2019